Stock Radar: Pharma stocks in focus! Laurus Labs looking attractive after 10% fall from 52-week high

Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity for short-term traders with a target above 500. The stock has reclaimed crucial moving averages and is supported by an upsloping trendline and reduced volume participation.